(Q37724483)

22 August 2017

1 reference

title

The immune response to rabies virus infection and vaccination (English)

1 reference

22 August 2017

0 references

0 references

rabies virus

1 reference

3

Anthony R Fooks

1 reference

22 August 2017

Nicholas Johnson

1

1 reference

22 August 2017

Adam F Cunningham

series ordinal

2

1 reference

22 August 2017

language of work or name

English

0 references

publication date

3 April 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

28

1 reference

22 August 2017

issue

23

1 reference

22 August 2017

page(s)

3896-3901

1 reference

Comparative analysis of the full genome sequence of European bat lyssavirus type 1 and type 2 with other lyssaviruses and evidence for a conserved transcription termination and polyadenylation motif in the G-L 3' non-translated region

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Emerging epidemiology of bat-associated cryptic cases of rabies in humans in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Airborne transmission of lyssaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

The long incubation period in rabies: delayed progression of infection in muscle at the site of exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Is the acetylcholine receptor a rabies virus receptor?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Management of rabies in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Prevalence of rabies specific antibodies in the Mexican free-tailed bat (Tadarida brasiliensis mexicana) at Lava Cave, New Mexico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Screening of active lyssavirus infection in wild bat populations by viral RNA detection on oropharyngeal swabs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Prevalence of rabies and LPM paramyxovirus antibody in non-hematophagous bats captured in the Central Pacific coast of Mexico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

European bat lyssavirus in Scottish bats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Effects of aerosolized rabies virus exposure on bats and mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Rabies and other lyssavirus diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Survival after treatment of rabies with induction of coma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Immunoglobulin (IgG) and (IgM) antibody responses to rabies vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Immunization with a human diploid cell strain of rabies virus vaccine: two-year results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

An experimental study on the endurance of immunologic memory of intradermal micro-injection with rabies vaccine and boosting immune effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Safety and immunogenicity of the intradermal Thai red cross (2-2-2-0-1-1) post exposure vaccination regimen in the Indian population using purified chick embryo cell rabies vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Immunogenicity and efficacy of the oral rabies vaccine SAD B19 in foxes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Human immune response to rabies nucleocapsid and glycoprotein antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Epidemiology of human rabies in the United States, 1980 to 1996.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Paralytic rabies after a two week holiday in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Fatal Human Rabies Caused by European Bat Lyssavirus Type 2a Infection in Scotland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Failure of therapeutic coma and ketamine for therapy of human rabies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

T cells traffic from brain to cervical lymph nodes via the cribroid plate and the nasal mucosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Pathogenesis of neurotropic herpesviruses: role of viral glycoproteins in neuroinvasion and transneuronal spread

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Intrinsic responses to Borna disease virus infection of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Suppression of Cell‐Mediated Immunity by Street Rabies Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

The antigen-specific cell-mediated immune response in mice is suppressed by infection with pathogenic lyssaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Induction of immunoreactive interleukin-1 beta and tumor necrosis factor-alpha in the brains of rabies virus infected rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Rabies virus stimulates nitric oxide production and CXC chemokine ligand 10 expression in macrophages through activation of extracellular signal-regulated kinases 1 and 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Common host genes are activated in mouse brain by Japanese encephalitis and rabies viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Apoptosis and rabies virus neuroinvasion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Molecular detection of rabies encephalitis and correlation with cytokine expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Viruses selectively upregulate Toll-like receptors in the central nervous system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Lyssavirus infection activates interferon gene expression in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Antibody-mediated clearance of viruses from the mammalian central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Antigen detection in vivo after immunization with different presentation forms of rabies virus antigen, II. Cellular, but not humoral, systemic immune responses against rabies virus immune-stimulating complexes are macrophage dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Comparative pathological study of the murine brain after experimental infection with classical rabies virus and European bat lyssaviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

7 January 2021

Antibody response to rabies virus in Syrian hamsters

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

7 January 2021

Rabies virus infects mouse and human lymphocytes and induces apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

7 January 2021

Basis of rabies virus neurovirulence in mice: expression of major histocompatibility complex class I and class II mRNAs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.039

7 January 2021

10.1016/J.VACCINE.2010.03.039

Identifiers

DOI

1 reference

22 August 2017

1 reference